Onkologie. 2014:8(1):11-14

The role of radical prostatectomy in the treatment of prostate cancer

Petr Macek
Urologická klinika Všeobecné fakultní nemocnice a 1. lékařské fakulty Univerzity Karlovy v Praze

Incidence of prostate cancer increases worldwide. Despite progress in techniques such as active surveillance and improvement in non-surgical

methods, the radical prostatectomy remains an important form of prostate cancer management alone or as apart of multimodal therapy in

patients with high risk prostate cancer. During years of its use, there was a significant change in the understanding of prostate neuroanatomy,

which improved its safety, decreased perioperative morbidity and improved functional results. The article refers mainly to oncological



results: Despite we cannot completely devide them from the functional ones, because quality of life following radical prostatectomy is an

important aspect, which is unseparable part of discussion with patients with diagnosed prostate cancer. Regardless the availability of open

and minimally invasive radical prostatectomy we should not forget that an experience surgeon taking into consideration individal cancer

factors and patient’s preferences remains the most important variable in order to achieve optimal results.

Keywords: prostate cancer, radical prostatectomy, oncological and funtional outcomes

Published: March 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Macek P. The role of radical prostatectomy in the treatment of prostate cancer. Onkologie. 2014;8(1):11-14.
Download citation

References

  1. Young HH. VIII. Conservative Perineal Prostatectomy: The Results of Two Years' Experience and Report of Seventy-Five Cases. Ann Surg, 1905; 41(4): 549-557.
  2. Millin T. Retropubic prostatectomy; a new extravesical technique; report of 20 cases. Lancet, 1945; 2(6380): 693-696. Go to original source... Go to PubMed...
  3. Reiner WG, Walsh PC. An anatomical approach to the surgical management of the dorsal vein and Santorini's plexus during radical retropubic surgery. J Urol, 1979; 121(2): 198-200. Go to original source... Go to PubMed...
  4. Walsh PC, Donker PJ. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol, 1982; 128(3): 492-497. Go to original source... Go to PubMed...
  5. Walz J, Burnett AL, Costello AJ, et al. A critical analysis of the current knowledge of surgical anatomy related to optimization of cancer control and preservation of continence and erection in candidates for radical prostatectomy. Eur Urol, 2010; 57(2): 179-192. Go to original source... Go to PubMed...
  6. Heidenreich A, Bastian PJ, Bellmunt J, et al. Guidelines on Prostate Cancer. European Association of Urology Office, 2013; 2013: 154 s.
  7. Boris RS, Kaul SA, Sarle RC, et al. Radical prostatectomy: a single surgeon comparison of retropubic, perineal, and robotic approaches. Can J Urol, 2007; 14(3): 3566-3570.
  8. Ficarra V, Novara G, Artibani W, et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol, 2009; 55(5): 1037-1063. Go to original source... Go to PubMed...
  9. Carini M, Masieri L, Minervini A, et al. Oncological and functional results of antegrade radical retropubic prostatectomy for the treatment of clinically localised prostate cancer. Eur Urol, 2008; 53(3): 554-561. Go to original source... Go to PubMed...
  10. Schuessler WW, Schulam PG, Clayman RV, et al. Laparoscopic radical prostatectomy: initial short-term experience. Urology, 1997; 50(6): 854-857. Go to original source... Go to PubMed...
  11. Abbou CC, Hoznek A, Salomon L, et al. Remote laparoscopic radical prostatectomy carried out with a robot. Report of a case. Prog Urol, 2000; 10(4): 520-523. Go to PubMed...
  12. Rassweiler J, Wagner AA, Moazin M, et al. Anatomic nerve-sparing laparoscopic radical prostatectomy: comparison of retrograde and antegrade techniques. Urology, 2006; 68(3): 587-591; discussion 591-592. Go to original source... Go to PubMed...
  13. Grepl M. Radikální prostatektomie. Onkologie, 2010; 4(2): 72-74.
  14. Abdollah F, Schmitges J, Sun M, et al. Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: a population-based analysis. Int J Urol, 2012; 19(9): 836-844; author reply 844-845. Go to original source... Go to PubMed...
  15. Boorjian SA, Karnes RJ, Viterbo R, et al. Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer. Cancer, 2011; 117(13): 2883-2891. Go to original source... Go to PubMed...
  16. Bill-axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med, 2011; 364(18): 1708-1717. Go to original source... Go to PubMed...
  17. Sooriakumaran P, Srivastava A, Shariat SF, et al. A Multinational, Multi-institutional Study Comparing Positive Surgical Margin Rates Among 22393 Open, Laparoscopic, and Robot-assisted Radical Prostatectomy Patients. Eur Urol, 2013, publ. elektronicky, doi: 10.1016/j.eururo.2013.11.018. Go to original source... Go to PubMed...
  18. Salomon L, Levrel O, De La Taille A, et al. Localization of positive surgical margins after retropubic, perineal and laparoscopic radical prostatectomy. Prog Urol, 2002; 12(4): 628-634. Go to PubMed...
  19. Bolla M, Van Poppel H, Tombal B, et al. Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911). Lancet, 2012; 380(9858): 2018-2027. Go to original source... Go to PubMed...
  20. Stephenson AJ, Eggener SE, Hernandez AV, et al. Do Margins Matter? The Influence of Positive Surgical Margins on Prostate Cancer-Specific Mortality. Eur Urol, 2013, publ. elektronicky, doi: 10.1016/j.eururo.2013.08.036. Go to original source... Go to PubMed...
  21. Eggener SE, Scardino PT, Walsh PC, et al. Predicting 15year prostate cancer specific mortality after radical prostatectomy. J Urol, 2011; 185(3): 869-875. Go to original source... Go to PubMed...
  22. Briganti A, Spahn M, Joniau S, et al. Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis. Eur Urol, 2013; 63(4): 693-701. Go to original source... Go to PubMed...
  23. Suardi N, Larcher A, Haese A, et al. Indication for and Extension of Pelvic Lymph Node Dissection During Robot-assisted Radical Prostatectomy: An Analysis of Five European Institutions. Eur Urol, 2014, publ. elektronicky, doi: 10.1016/j.eururo.2013.12.059. Go to original source... Go to PubMed...
  24. Seiler R, Studer UE, Tschan K, et al. Removal of limited nodal disease in patients undergoing radical prostatectomy: Long-term results confirm a chance for cure. J Urol, 2013, publ. elektronicky, doi: 10.1016/j.juro.2013.11.029. Go to original source... Go to PubMed...
  25. Abdollah F, Karnes RJ, Suardi N, et al. Predicting Survival of Patients with Node-positive Prostate Cancer Following Multimodal Treatment. Eur Urol, 2013; publ. elektronicky, doi: 10.1016/j.eururo.2013.09.025. Go to original source...
  26. Briganti A, Karnes JR, Da Pozzo LF, et al. Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy. Eur Urol, 2009; 55(2): 261-270. Go to original source... Go to PubMed...
  27. Steuber T, Budaus L, Walz J, et al. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study. BJU Int, 2011; 107(11): 1755-1761. Go to original source... Go to PubMed...
  28. Waehre H, Vlatkovic L, Cvancarova M, et al. Fifteen-year mortality after radical prostatectomy: Which factors are available for patient counselling? Scand J Urol, 2013, publ. elektronicky, doi: 10.3109/21681805.2013.817483. Go to original source... Go to PubMed...
  29. Hruza M, Bermejo JL, Flinspach B, et al. Long-term oncological outcomes after laparoscopic radical prostatectomy. BJU Int, 2013; 111(2): 271-280. Go to original source... Go to PubMed...
  30. Sukumar S, Rogers CG, Trinh QD, et al. Oncological Outcomes after Robot-Assisted Radical Prostatectomy: Long Term Follow-up in 4,803 patients. BJU Int, 2013, publ. elektronicky, doi: 10.1111/bju.12404. Go to original source... Go to PubMed...
  31. Coelho RF, Rocco B, Patel MB, et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a critical review of outcomes reported by high-volume centers. J Endourol, 2010; 24(12): 2003-2015. Go to original source... Go to PubMed...
  32. Ficarra V, Novara G, Rosen RC, et al. Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol, 2012; 62(3): 405-417. Go to original source... Go to PubMed...
  33. Parsons JK, Bennett JL. Outcomes of retropubic, laparoscopic, and robotic-assisted prostatectomy. Urology, 2008; 72(2): 412-416. Go to original source... Go to PubMed...
  34. Aykan S, Singhal P, Nguyen D, et al. Perioperative, pathological and early continence outcomes comparing three-dimensional and two-dimensional display systems for laparoscopic radical prostatectomy- a retrospective, single-surgeon study. J Endourol, 2014, publ. elektronicky, doi: 10.1089/end.2013.0630. Go to original source... Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.